Clough Capital Partners L P Kura Oncology, Inc. Transaction History

Clough Capital Partners L P

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $391,066 - $550,840	-25,361 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$29.0 - $41.62 $733,700 - $1.05 Million	-25,300 Reduced 49.94%	25,361 $828,000
Q3 2020 Nov 17, 2020	SELL	$16.3 - $30.64 $275,470 - $517,816	-16,900 Reduced 25.01%	50,661 $1.55 Million
Q1 2020 May 15, 2020	SELL	$6.45 - $14.04 $19,995 - $43,524	-3,100 Reduced 4.39%	67,561 $672,000
Q4 2019 Feb 14, 2020	SELL	$12.97 - $15.94 $25,940 - $31,880	-2,000 Reduced 2.75%	70,661 $972,000
Q3 2019 Nov 14, 2019	SELL	$14.75 - $20.87 $56,050 - $79,306	-3,800 Reduced 4.97%	72,661 $1.1 Million
Q2 2019 Aug 14, 2019	SELL	$14.71 - $19.79 $55,898 - $75,202	-3,800 Reduced 4.73%	76,461 $1.51 Million
Q3 2018 Nov 14, 2018	SELL	$16.65 - $21.85 $767,564 - $1.01 Million	-46,100 Reduced 36.48%	80,261 $1.41 Million
Q2 2018 Aug 14, 2018	SELL	$14.8 - $18.8 $623,080 - $791,480	-42,100 Reduced 24.99%	126,361 $2.3 Million
Q1 2018 May 15, 2018	SELL	$14.5 - $23.4 $642,350 - $1.04 Million	-44,300 Reduced 20.82%	168,461 $3.16 Million
Q4 2017 Feb 14, 2018	SELL	$13.5 - $16.65 $163,350 - $201,464	-12,100 Reduced 5.38%	212,761 $3.26 Million
Q3 2017 Nov 14, 2017	BUY	$6.05 - $14.95 $1.36 Million - $3.36 Million	224,861	224,861 $3.36 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.